Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Compounds are not FDA-approved
AOD 9604 Side Effects: What Six Clinical Trials Found The safety data on AOD 9604 is stronger than for most investigational peptides, precisely because six formal clinical trials were conducted before development halted
symbols gene set collection
Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Studies on Liver and Metabolic Markers Tesamorelin has been investigated in relation to hepatic lipid accumulation and liver fibrosis progression
Support for Metabolic Optimization Protocols: AOD-9604 can be integrated into comprehensive metabolic health programs alongside proper nutrition, exercise, and other interventions
US$ 23.11
US$ 27.09
US$ 29.95
US$ 22.97
